A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancer.
Jimenez JE, Abdelhafez A, Mittendorf EA, Elshafeey N, Yung JP, Litton JK, Adrada BE, Candelaria RP, White J, Thompson AM, Huo L, Wei P, Tripathy D, Valero V, Yam C, Hazle JD, Moulder SL, Yang WT, Rauch GM.
Jimenez JE, et al. Among authors: yung jp.
Eur J Radiol. 2022 Apr;149:110220. doi: 10.1016/j.ejrad.2022.110220. Epub 2022 Feb 15.
Eur J Radiol. 2022.
PMID: 35193025